Q2 2025 Hypera SA Earnings Call Transcript
Key Points
- Hypera SA (HYPMY) achieved a sellout growth of 5.5% in the retail market, surpassing the 5.2% growth of its addressable market.
- The company successfully completed its working capital optimization process, reducing the average receivable term from 116 days to 60 days and decreasing working capital investment from 49% to 32% of net revenue.
- Hypera SA (HYPMY) declared interest on equity of 185 million, maintaining consistency with recent quarters.
- The company expanded its production capacity and launched new products across all business units.
- Hypera SA (HYPMY) strengthened its corporate governance with a new board composition and a new controlling block, aiming to enhance strategic decision-making and value creation for shareholders.
- Despite sellout growth, net revenue did not increase due to the lingering impact of the working capital optimization process.
- There was a slight decrease in sales in the institutional market, impacting overall performance.
- The company faced challenges in the analgesics market due to a migration towards generics and a reduction in dengue fever cases.
- Hypera SA (HYPMY) is still assessing the ideal inventory levels post-working capital optimization, indicating potential inefficiencies.
- The institutional market experienced a drop in sales, particularly in the public sector, affecting overall market performance.
Good morning ladies and gentlemen. Welcome to HPharma video conference that will discuss the earnings for the 2nd quarter of 2025. We have with us Mr. Bruno Oliveira, CEO and Mr. Ramon Sanchez, CFO and director of investor relations. This event will be recorded and the recording can be accessed on the website of the company, RI.hypea.com.r.
All participants will only be watching the video conference during the presentation, and after that, we'll follow up with a Q&A session when we're going to give you more instructions. Before we move forward, I'd like to highlight that Information contained in this conference call may contain projections or statements about future expectations. These statements are subject to known and unknown risks and uncertainties that may lead these expectations to not occur or to be substantially different from expected. Now I'll give the floor to Mr. Brno Oliveira, who will start the presentation. Mr. Brno, you have the 4
Good morning everyone. Thank you for joining our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
